ArticleACS omega2022
Mesoporous Carbon-Supported Pd Nanoparticles in the Metallic State-Catalyzed Acylation of Amides with Aryl Esters via C-O Activation.
Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Carbon, an abundant, inexpensive, and nonmetallic material, is an inimitable support in heterogeneous catalysis, and variable carbonaceous materials have been utilized to support metal nanoparticle catalysts. We developed an efficient and stable heterogeneous catalyst with highly dispersed metallic palladium nanoparticles embedded in an ordered pore channel of mesoporous carbon and first applied the catalyst to construct imides from amides using aryl esters as an acylation reagent via C-O activation. The catalyst represents excellent catalytic performance and could be reused and recycled five times without any significant decrease in activity. The heterogeneous nature of metallic state palladium was proven to be the active center in the acylation reaction.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.